JARDIANCE 25MG EMPAGLIFLOZIN 10MG – 30 TABS

Jardiance (empagliflozin) is an oral medication primarily used to manage type 2 diabetes mellitus. It belongs to a class of drugs known as SGLT2 inhibitors, which work by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine and lower blood sugar levels. Jardiance is often prescribed alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.

In addition to its primary use in diabetes management, Jardiance has also been shown to have cardiovascular benefits, reducing the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. Furthermore, it may help with weight loss and has a favorable effect on blood pressure. The typical dosage is 25 mg, and it is available in film-coated tablets, often supplied in packs of 30. Regular monitoring of kidney function and blood sugar levels is recommended during treatment.